» Articles » PMID: 27057848

The Effect of Malaria and HIV Co-Infection on Anemia: A Meta-Analysis

Overview
Specialty General Medicine
Date 2016 Apr 9
PMID 27057848
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Malaria and human immunodeficiency virus (HIV) infections are globally important public health concerns. The objectives of this study were (i) to determine the prevalence of malaria and HIV co-infections in people living in endemic countries, and (ii) to assess the effect of co-infection on anemia.Studies were searched on electronic databases including PubMed, Embase, Medline, Google Scholar, and African Journals Online. Observational studies, assessing the prevalence of co-infection and reporting its association with anemia, were included. The methodological quality of included studies was assessed using a tool called the risk of bias assessment for non-randomized studies. Heterogeneity among studies was investigated with the I-square test. Pooled prevalence of the co-infection and its 95% confidence interval (CI) were estimated using the random-effect model, reflected on heterogeneity among studies. Summary odds ratio (OR), summary standardized mean difference (SMD), and their corresponding 95% CIs were estimated, as appropriate. Subgroup analysis and meta-regression were performed for robustness of results. Publication bias was assessed by visualization of a funnel plot.Twenty-three studies were included in the present study. Overall, the pooled prevalence of co-infection was 19% (95% CI: 15-23%, I: 98.1%), showing 26% (95% CI: 20-32%, I: 98.7%) in adults, 12% (95% CI: 7-17%, I: 95.0) in pregnant women, and 9% (95% CI: 6-11%, I: 68.6%) in children. Anemia was comparable between the monoinfected and co-infected adults (summary OR: 1.49, 95% CI: 0.93-2.37) and increased by 49% in co-infected pregnant women (summary OR: 1.49, 95% CI: 1.14-1.94). The mean hemoglobin concentration was significantly lower in the co-infected group than the monoinfected group (summary SMD: -0.47, 95% CI: -0.61 to -0.33). The results of meta-regression on the prevalence of co-infection using the publication year and total population as covariates showed the I value remained high implying a de facto random distribution of heterogeneity. An asymmetrical funnel plot indicated the presence of publication bias. Due to heterogeneity of the studies in this review, the results have to be interpreted with caution.The findings of this study suggest that the prevalence of malaria and HIV co-infection, particularly in pregnant women, requires special attention from healthcare personnel. Better understanding of the co-infection is crucial for designing treatment strategies. Future well-powered, prospective designs assessing the interaction between malaria and HIV are recommended.

Citing Articles

PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults.

Tumbo A, Lorenz F, Yang A, Sefried S, Schindler T, Mpina M EBioMedicine. 2024; 108:105364.

PMID: 39353279 PMC: 11464252. DOI: 10.1016/j.ebiom.2024.105364.


Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women.

Pons-Duran C, Wassenaar M, Yovo K, Marin-Carballo C, Briand V, Gonzalez R Cochrane Database Syst Rev. 2024; 9:CD006689.

PMID: 39324693 PMC: 11426187. DOI: 10.1002/14651858.CD006689.pub3.


Climate variability, socio-economic conditions and vulnerability to malaria infections in Mozambique 2016-2018: a spatial temporal analysis.

Armando C, Rocklov J, Sidat M, Tozan Y, Mavume A, Bunker A Front Public Health. 2023; 11:1162535.

PMID: 37325319 PMC: 10267345. DOI: 10.3389/fpubh.2023.1162535.


Occurrence and clinical features of HIV and malaria in co-infected individuals in Osun State, Nigeria.

Adeola O, Kolawole O, Yemi A, Hilda A, Samson A, Kola O J Family Med Prim Care. 2022; 11(9):5332-5339.

PMID: 36505610 PMC: 9731083. DOI: 10.4103/jfmpc.jfmpc_1361_21.


Evidence of and deaths from malaria and severe pneumonia co-infections in malaria-endemic areas: a systematic review and meta-analysis.

Mala W, Wilairatana P, Milanez G, Masangkay F, Kotepui K, Kotepui M Sci Rep. 2022; 12(1):17344.

PMID: 36243777 PMC: 9569341. DOI: 10.1038/s41598-022-22151-x.


References
1.
Mouala C, Houze S, Guiguet M, Abboud P, Pialoux G, Viget N . Imported malaria in HIV-infected patients enrolled in the ANRS CO4 FHDH study. J Acquir Immune Defic Syndr. 2008; 49(1):55-60. DOI: 10.1097/QAI.0b013e31817e635b. View

2.
Berg A, Patel S, Aukrust P, David C, Gonca M, Berg E . Increased severity and mortality in adults co-infected with malaria and HIV in Maputo, Mozambique: a prospective cross-sectional study. PLoS One. 2014; 9(2):e88257. PMC: 3914956. DOI: 10.1371/journal.pone.0088257. View

3.
Akinbo F, Omoregie R . Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy (HAART) in Benin City, Nigeria. J Res Health Sci. 2012; 12(1):15-8. View

4.
Douglas N, Anstey N, Buffet P, Poespoprodjo J, Yeo T, White N . The anaemia of Plasmodium vivax malaria. Malar J. 2012; 11:135. PMC: 3438072. DOI: 10.1186/1475-2875-11-135. View

5.
Greenberg A, Nsa W, Ryder R, Medi M, Nzeza M, Kitadi N . Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children. N Engl J Med. 1991; 325(2):105-9. DOI: 10.1056/NEJM199107113250206. View